According to statistics from the International Federation IDF in 2017, China has become the country with the most widespread diabetes prevalence. The number of adults with diabetes (20-79 years old) has reached 114 million. It is estimated that by 2025, the number of global diabetes patients will reach at least 300 million. In the treatment of diabetes, insulin is one of the most effective drugs to control blood sugar. Patients with type 1 diabetes depend on insulin to maintain life, and insulin must be used to control hyperglycemia and reduce the risk of diabetes complications. Type 2 diabetes (T2DM) patients still need to use insulin to control hyperglycemia and reduce the risk of diabetic complications when oral hypoglycemic drugs are ineffective or contraindicated. Especially in patients with a longer course of disease, insulin therapy may be the most important or even necessary measure to control blood sugar. However, the traditional way of insulin injection with needles has a certain impact on the psychology of patients. Some patients are reluctant to inject insulin due to fear of needles or pain. In addition, the repeated use of injection needles will also affect the accuracy of insulin injection and increase the chance of subcutaneous induration.
At present, needle-free injection is suitable for all people who can receive needle injection. Needlefree insulin injection can bring better injection experience and therapeutic effect to diabetic patients, and there is no risk of subcutaneous induration and needle scratch after injection
In 2012, China approved the launch of the first needle-free insulin syringe with independent intellectual property rights. After years of continuous research and development, in June 2018, Beijing QS launched the world's smallest and lightest integrated QS- P-type needleless syringe. In 2021, a needlefree syringe for children to inject hormones and produce hormones. At present, the work covering tertiary hospitals in various provinces, municipalities and autonomous regions across the country has been fully carried out.
Now the needle-free injection technology has matured, the safety and actual effect of the technology have also been clinically confirmed, and the prospect of widespread clinical application is very considerable. The emergence of needle-free injection technology has brought good news to patients who need long-term insulin injection. Insulin can not only be injected without needles, but also better absorbed and controlled than that with needles.
Post time: Sep-29-2022